Resolution Therapeutics Expands Regenerative Macrophage Therapy with In Vivo Platform
EDINBURGH & LONDON, UK, June 17, 2026 Resolution Therapeutics announced the expansion of its pipeline for inflammatory and fibrotic...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
EDINBURGH & LONDON, UK, June 17, 2026 Resolution Therapeutics announced the expansion of its pipeline for inflammatory and fibrotic...
CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...
